Loading company…
Tahoe Therapeutics uses AI and in vivo data to study drugs and cellular responses.
Based in California, US, Tahoe Therapeutics develops a platform that generates high-resolution in vivo data at single-cell resolution. It measures changes in cell states and drug-cell interactions to help researchers study drug efficacy across patients. In August 2025, the company raised USD 30 million in venture funding led by Amplify Partners, with new and returning investors participating. It plans to use the funds to study how drugs affect human cells.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in